Iceland vs Oman: New cases tested for RR-/MDR-TB
Iceland
100.0%
in 2024
Oman
100.0%
in 2024
Iceland rank
1st
Oman rank
1st
New cases tested for RR-/MDR-TB over time
- Iceland
- Oman
How they compare
Iceland currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 1 time across 17 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 1st and Oman ranks 1st of 192 countries.
Across the 3 decades both report, Iceland averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Iceland | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 71.2% | 28.8% | Iceland |
| 2010s | 92.2% | 95.9% | 3.7% | Oman |
| 2020s | 50.0% | 89.5% | 39.5% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Iceland or Oman?
- Iceland, at 100.0% against 100.0% in Oman as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Iceland and Oman?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Oman?
- 17 years are reported by both, from 2005 to 2024.
- How do Iceland and Oman rank globally for new cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Oman ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.